Endo Inc. (NDOI)
| Market Cap | 1.93B |
| Revenue (ttm) | 1.18B |
| Net Income (ttm) | -730.86M |
| Shares Out | 76.21M |
| EPS (ttm) | -9.60 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,628,500 |
| Average Volume | 121,549 |
| Open | 27.70 |
| Previous Close | 28.25 |
| Day's Range | 25.30 - 27.75 |
| 52-Week Range | 22.50 - 31.40 |
| Beta | n/a |
| RSI | 24.29 |
| Earnings Date | Mar 7, 2025 |
About Endo Inc.
Endo Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells various pharmaceutical products in the United States and internationally. It operates through four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The Branded Pharmaceuticals segment offers products for the treatment of conditions in urology, orthopedics, and endocrinology. Its products include XIAFLEX, a non-surgical treatment for Peyronie’s Disease for adult men with a collagen plaque an... [Read more]
Full Company ProfileFinancial Performance
In 2024, Endo Inc.'s revenue was $1.18 billion, a decrease of -41.43% compared to the previous year's $2.01 billion. Losses were -$730.86 million, -70.17% less than in 2023.
Financial StatementsNews
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Endo, Inc.
NEW YORK , March 13, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Endo, Inc. (OTCQX: NDOI) and its board of directors concerning the proposed acquisitio...
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Endo, Inc. - NDOI
NEW YORK , March 13, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 IS...
NDOI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Endo, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Endo, Inc. (OTCQX: NDOI) and Mallinckrodt plc is fair to Endo shareholders. Under the t...
Shareholder Alert: The Ademi Firm Investigates Whether Endo, Inc. Is Obtaining a Fair Price for Its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Endo (OTCQX: NDOI) for possible breaches of fiduciary duty and other violations of law in its transaction with Mallinckrodt. Click here to l...
Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm
Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S. footprint.
Mallinckrodt and Endo plan merger as they look to recover from opioid litigation
The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in 2025 and at least $150 million of annual operating synergies by year three...
Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal
Mallinckrodt and Endo , drugmakers with a shared history of facing U.S. opioid litigation, have agreed to merge in a deal valued at nearly $7 billion.
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Endo achieved 2024 revenues and adjusted EBITDA expectations, while progressing the Company's strategic priorities XIAFLEX® hit record revenues of $516 million in 2024, up 9% versus 2023 The Company p...
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Transaction Brings Together Two Highly Complementary Businesses to Broaden Patient Access and Develop New Therapies to Address Unmet Patient Needs Combined Company Expected to Benefit from Immediate S...
Drugmakers Mallinckrodt, Endo in talks to merge, Bloomberg News reports
Mallinckrodt Pharmaceuticals and Endo are exploring a potential merger that could be valued at about $7 billion, Bloomberg News reported on Wednesday, citing people with knowledge of the matter.
Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
MALVERN, Pa. , March 12, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or C...
Endo Announces Divestiture of International Pharmaceuticals Business
MALVERN, Pa. , March 11, 2025 /PRNewswire/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals ...
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
MALVERN, Pa. , March 10, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it has rescheduled the release of its fourth quarter and full year 2024 financial ...
Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach - Levi & Korsinsky, LLP Launches Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that comp...
Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach - Levi & Korsinsky, LLP Launches Investigation
NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenterrecentlydisclosed that it suffered a data breach that compromised...
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach under Investigation by Levi & Korsinsky, LLP
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
MALVERN, Pa. , Feb. 21, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report fourth quarter and full year 2024 financial results on March 11, 202...
Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach - Levi & Korsinsky, LLP Launches Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset Surgi Center recently disclosed that it suffered a data breach that com...
Levi & Korsinsky, LLP Investigates Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter Data Breach
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Endo Group, LLC d/b/a Endo Group, Garden City SurgiCenter, and Syosset SurgiCenter recently disclosed that it suffered a data breach that compromis...
Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)
Campaign builds on the momentum of Endo's disease awareness efforts. Commercial features a real patient—who was an untreated patient in a prior Endo video series—and his wife, sharing their personal e...